Curcumin uptake and metabolism

被引:213
作者
Metzler, Manfred [1 ]
Pfeiffer, Erika [1 ]
Schulz, Simone I. [1 ]
Dempe, Julia S. [1 ]
机构
[1] KIT, Dept Chem & Biosci, D-76131 Karlsruhe, Germany
关键词
curcumin; bioavailability; degradation; metabolism; intestinal absorption; CHEMOPREVENTIVE AGENT CURCUMIN; I CLINICAL-TRIAL; INTESTINAL-ABSORPTION; DEGRADATION-PRODUCTS; RAT; PERMEABILITY; TISSUE; GLUCURONIDATION; ANTICANCER; STABILITY;
D O I
10.1002/biof.1042
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Curcumin (CUR) is the major orange pigment of turmeric and believed to exert beneficial health effects in the gastrointestinal tract and numerous other organs after oral intake. However, an increasing number of animal and clinical studies show that the concentrations of CUR in blood plasma, urine, and peripheral tissues, if at all detectable, are extremely low even after large doses. The evidence and possible reasons for the very poor systemic bioavailablity of CUR after oral administration are discussed in this brief review. Major factors are the chemical instability of CUR at neutral and slightly alkaline pH, its susceptibility to autoxidation, its avid reductive and conjugative metabolism, and its poor permeation from the intestinal lumen to the portal blood. In view of the very low intestinal bioavailablity, it is difficult to attribute the putative effects observed in peripheral organs to CUR. Therefore, metabolites and/or degradation products of CUR should be taken into consideration as mediators of the pharmacological activity. (c) 2012 BioFactors, 39(1):1420, 2013.
引用
收藏
页码:14 / 20
页数:7
相关论文
共 43 条
  • [1] Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature
    Anand, Preetha
    Thomas, Sherin G.
    Kunnumakkara, Ajaikumar B.
    Sundaram, Chitra
    Harikumar, Kuzhuvelil B.
    Sung, Bokyung
    Tharakan, Sheeja T.
    Misra, Krishna
    Priyadarsini, Indira K.
    Rajasekharan, Kallikat N.
    Aggarwal, Bharat B.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2008, 76 (11) : 1590 - 1611
  • [2] Bioavailability of curcumin: Problems and promises
    Anand, Preetha
    Kunnumakkara, Ajaikumar B.
    Newman, Robert A.
    Aggarwal, Bharat B.
    [J]. MOLECULAR PHARMACEUTICS, 2007, 4 (06) : 807 - 818
  • [3] Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma
    Asai, A
    Miyazawa, T
    [J]. LIFE SCIENCES, 2000, 67 (23) : 2785 - 2793
  • [4] Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia
    Carroll, Robert E.
    Benya, Richard V.
    Turgeon, Danielle Kim
    Vareed, Shaiju
    Neuman, Malloree
    Rodriguez, Luz
    Kakarala, Madhuri
    Carpenter, Philip M.
    McLaren, Christine
    Meyskens, Frank L., Jr.
    Brenner, Dean E.
    [J]. CANCER PREVENTION RESEARCH, 2011, 4 (03) : 354 - 364
  • [5] Cheng AL, 2001, ANTICANCER RES, V21, P2895
  • [6] Metabolism and permeability of curcumin in cultured Caco-2 cells
    Dempe, Julia S.
    Scheerle, Romy K.
    Pfeiffer, Erika
    Metzler, Manfred
    [J]. MOLECULAR NUTRITION & FOOD RESEARCH, 2013, 57 (09) : 1543 - 1549
  • [7] CurcuminuFrom Molecule to Biological Function
    Esatbeyoglu, Tuba
    Huebbe, Patricia
    Ernst, Insa M. A.
    Chin, Dawn
    Wagner, Anika E.
    Rimbach, Gerald
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2012, 51 (22) : 5308 - 5332
  • [8] Garcea G, 2005, CANCER EPIDEM BIOMAR, V14, P120
  • [9] Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration
    Garcea, G
    Jones, DJL
    Singh, R
    Dennison, AR
    Farmer, PB
    Sharma, RA
    Steward, WP
    Gescher, AJ
    Berry, DP
    [J]. BRITISH JOURNAL OF CANCER, 2004, 90 (05) : 1011 - 1015
  • [10] Vanillin and ferulic acid: not the major degradation products of curcumin
    Gordon, Odaine N.
    Schneider, Claus
    [J]. TRENDS IN MOLECULAR MEDICINE, 2012, 18 (07) : 361 - 363